Vasilios Pergialiotis1, Zini Mudiaga2, Despina N Perrea3, Stergios K Doumouchtsis3,2,4. 1. Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, 6, Danaidon str, 15232, Halandri, Greece. pergialiotis@yahoo.com. 2. Department of Obstetrics and Gynaecology, Epsom & St Helier University Hospitals NHS Trust, London, UK. 3. Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, 6, Danaidon str, 15232, Halandri, Greece. 4. St George's University of London, London, UK.
Abstract
INTRODUCTION AND HYPOTHESIS: De novo overactive bladder (OAB) is a known complication of midurethral sling surgery for the treatment of stress urinary incontinence. To date, differences in the incidence of de novo OAB following the use of different types of midurethral sling remain relatively unknown. The purpose of the present systematic review was to evaluate this incidence and summarize current evidence. METHODS: We systematically searched the literature using the MEDLINE, Embase, Scopus, ClinicalTrials.gov, LILACS and Cochrane Central Register of Controlled Trials databases as well as the grey literature and references from the electronically retrieved articles. For comparisons of proportions, we used the chi-squared test. All reported analyses were designed as two-tailed. Statistical significance was set at p < 0.05. RESULTS: Finally, 32 studies were included in this systematic review, with a total of 3,139 patients who had undergone midurethral sling procedures that included transobturator tapes (TOT), retropubic tapes (TVT) or single-incision tapes (mini-slings). The overall incidence of de novo OAB was 11.5% in nonrandomized studies (280 women) and 6.4% in randomized studies (50 women). In relation to the type of midurethral sling, the incidence of de novo OAB was 9.7% for mini-slings, 11.2% for TVT-O, 8.7% for TOT and 9.8% for TVTs. The chi-squared test did not reveal significant differences (p = 0.58). CONCLUSIONS: Current evidence suggests that the overall incidence of de novo OAB following midurethral sling procedures is approximately 9%. There is not enough evidence to support differences in the effects of the different types of sling with regard to this particular postoperative complication.
INTRODUCTION AND HYPOTHESIS: De novo overactive bladder (OAB) is a known complication of midurethral sling surgery for the treatment of stress urinary incontinence. To date, differences in the incidence of de novo OAB following the use of different types of midurethral sling remain relatively unknown. The purpose of the present systematic review was to evaluate this incidence and summarize current evidence. METHODS: We systematically searched the literature using the MEDLINE, Embase, Scopus, ClinicalTrials.gov, LILACS and Cochrane Central Register of Controlled Trials databases as well as the grey literature and references from the electronically retrieved articles. For comparisons of proportions, we used the chi-squared test. All reported analyses were designed as two-tailed. Statistical significance was set at p < 0.05. RESULTS: Finally, 32 studies were included in this systematic review, with a total of 3,139 patients who had undergone midurethral sling procedures that included transobturator tapes (TOT), retropubic tapes (TVT) or single-incision tapes (mini-slings). The overall incidence of de novo OAB was 11.5% in nonrandomized studies (280 women) and 6.4% in randomized studies (50 women). In relation to the type of midurethral sling, the incidence of de novo OAB was 9.7% for mini-slings, 11.2% for TVT-O, 8.7% for TOT and 9.8% for TVTs. The chi-squared test did not reveal significant differences (p = 0.58). CONCLUSIONS: Current evidence suggests that the overall incidence of de novo OAB following midurethral sling procedures is approximately 9%. There is not enough evidence to support differences in the effects of the different types of sling with regard to this particular postoperative complication.
Authors: Konrad Futyma; Paweł Miotła; Aleksandra Bartuzi; Izabela Winkler; Ernest Lis; Beata Kulik-Rechberger; Tomasz Rechberger Journal: Ginekol Pol Date: 2014-09 Impact factor: 1.232
Authors: Asnat Groutz; Aviad Cohen; Ronen Gold; David Pauzner; Joseph B Lessing; David Gordon Journal: Neurourol Urodyn Date: 2011-03 Impact factor: 2.696
Authors: Andrea Braga; Giorgio Caccia; Giovanni Ruggeri; Luca Regusci; Andrea Papadia; Maurizio Serati Journal: Int Urogynecol J Date: 2019-08-28 Impact factor: 2.894
Authors: Anne-Claude Fahrni; Cornelia Betschart; Jean Bouquet de la Jolinière; Jean-Bernard Dubuisson; Anis Feki; Attila Louis Major Journal: Int Urogynecol J Date: 2021-10-02 Impact factor: 1.932
Authors: Jacek K Szymański; Aneta Słabuszewska-Jóźwiak; Kornelia Zaręba; Grzegorz Jakiel Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-05-23 Impact factor: 1.195
Authors: Jordi Sabadell; Anna Pereda-Núñez; Fernando Ojeda-de-Los-Santos; Manuel Urbaneja; Carmen González-García; Narcís Camps-Lloveras; Àngela Pérez-Plantado; Judit Canet-Rodríguez; Maria Paz Pérez-Espejo; Nuria Rodríguez-Mias; Núria Sarasa-Castelló; Marta Palau; Anabel Montero-Armengol; Sabina Salicrú; Antonio Gil-Moreno; Jose L Poza Journal: Neurourol Urodyn Date: 2020-12-01 Impact factor: 2.367